Can a simple scan reveal why muscles tire in phosphate diabetes?
NCT ID NCT06921720
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study uses a special MRI technique to measure energy molecules (ATP and phosphate) in the leg muscles of people with phosphate diabetes, a condition that causes bone pain and muscle fatigue. By comparing measurements at rest and during exercise, researchers hope to uncover the link between low phosphate levels and muscle weakness. The goal is to find objective markers of muscle health that could improve understanding of the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide objective biomarkers to assess muscle metabolism in phosphate diabetes, potentially guiding future treatments.
- What could go wrong
- This is an observational study with no intervention, so it cannot directly improve outcomes. The findings may not translate into clinical benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHOSPHATE DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Edouard Herriot, Hospices Civils de Lyon
RECRUITINGLyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital femme mère enfant, hospices civils de Lyon
NOT_YET_RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What It's really like: teens with XLH share their journey as bones stop growing
- Global XLH registry aims to map the disease's journey from childhood to adulthood
- New hope for rare bone disease: first human trial of KK8123 begins
- XLH study: watching the disease, not curing it
- XLH patients observed for a decade to uncover disease secrets
- Can a vitamin d pill improve bone health in rare genetic disease?